Literature DB >> 23613529

The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1).

Sara L Morales-Lázaro1, Sidney A Simon, Tamara Rosenbaum.   

Abstract

Pain is a physiological response to a noxious stimulus that decreases the quality of life of those sufferring from it. Research aimed at finding new therapeutic targets for the treatment of several maladies, including pain, has led to the discovery of numerous molecular regulators of ion channels in primary afferent nociceptive neurons. Among these receptors is TRPV1 (transient receptor potential vanilloid 1), a member of the TRP family of ion channels. TRPV1 is a calcium-permeable channel, which is activated or modulated by diverse exogenous noxious stimuli such as high temperatures, changes in pH, and irritant and pungent compounds, and by selected molecules released during tissue damage and inflammatory processes. During the last decade the number of endogenous regulators of TRPV1's activity has increased to include lipids that can negatively regulate TRPV1, as is the case for cholesterol and PIP2 (phosphatidylinositol 4,5-biphosphate) while, in contrast, other lipids produced in response to tissue injury and ischaemic processes are known to positively regulate TRPV1. Among the latter, lysophosphatidic acid activates TRPV1 while amines such as N-acyl-ethanolamines and N-acyl-dopamines can sensitize or directly activate TRPV1. It has also been found that nucleotides such as ATP act as mediators of chemically induced nociception and pain and gases, such as hydrogen sulphide and nitric oxide, lead to TRPV1 activation. Finally, the products of lipoxygenases and omega-3 fatty acids among other molecules, such as divalent cations, have also been shown to endogenously regulate TRPV1 activity. Here we provide a comprehensive review of endogenous small molecules that regulate the function of TRPV1. Acting through mechanisms that lead to sensitization and desensitization of TRPV1, these molecules regulate pathways involved in pain and nociception. Understanding how these compounds modify TRPV1 activity will allow us to comprehend how some pathologies are associated with its deregulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613529      PMCID: PMC3717213          DOI: 10.1113/jphysiol.2013.251751

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  97 in total

1.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

2.  Localization of the PIP2 sensor of TRPV1 ion channels.

Authors:  Carmen A Ufret-Vincenty; Rebecca M Klein; Li Hua; Juan Angueyra; Sharona E Gordon
Journal:  J Biol Chem       Date:  2011-01-11       Impact factor: 5.157

3.  Identification of a binding motif in the S5 helix that confers cholesterol sensitivity to the TRPV1 ion channel.

Authors:  Giovanni Picazo-Juárez; Silvina Romero-Suárez; Andrés Nieto-Posadas; Itzel Llorente; Andrés Jara-Oseguera; Margaret Briggs; Thomas J McIntosh; Sidney A Simon; Ernesto Ladrón-de-Guevara; León D Islas; Tamara Rosenbaum
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

4.  Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.

Authors:  L Cristino; L de Petrocellis; G Pryce; D Baker; V Guglielmotti; V Di Marzo
Journal:  Neuroscience       Date:  2006-04-17       Impact factor: 3.590

Review 5.  Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.

Authors:  Karsten H Weylandt; Cheng-Ying Chiu; Beate Gomolka; Simon F Waechter; Bertram Wiedenmann
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-02-03       Impact factor: 3.072

Review 6.  Multisteric TRPV1 nocisensor: a target for analgesics.

Authors:  János Szolcsányi; Zoltán Sándor
Journal:  Trends Pharmacol Sci       Date:  2012-10-12       Impact factor: 14.819

Review 7.  Lysophosphatidic acid: chemical signature of neuropathic pain.

Authors:  Hiroshi Ueda; Hayato Matsunaga; Omotuyi I Olaposi; Jun Nagai
Journal:  Biochim Biophys Acta       Date:  2012-08-29

8.  Hydrogen sulfide (H2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder.

Authors:  Riccardo Patacchini; Paolo Santicioli; Sandro Giuliani; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

9.  Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia.

Authors:  Jieun Shin; Hawon Cho; Sun Wook Hwang; Jooyoung Jung; Chan Young Shin; Soon-Youl Lee; So Hee Kim; Myung Gull Lee; Young Hae Choi; Jinwoong Kim; Nicole Alessandri Haber; David B Reichling; Sachia Khasar; Jon D Levine; Uhtaek Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

10.  Ca2+/calmodulin modulates TRPV1 activation by capsaicin.

Authors:  Tamara Rosenbaum; Ariela Gordon-Shaag; Mika Munari; Sharona E Gordon
Journal:  J Gen Physiol       Date:  2004-01       Impact factor: 4.086

View more
  37 in total

1.  Recovery from tachyphylaxis of TRPV1 coincides with recycling to the surface membrane.

Authors:  Quan Tian; Juan Hu; Chang Xie; Kaidi Mei; Cuong Pham; Xiaoyi Mo; Régine Hepp; Sylvia Soares; Fatiha Nothias; Yuanyuan Wang; Qiang Liu; Fen Cai; Bo Zhong; Dongdong Li; Jing Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-25       Impact factor: 11.205

Review 2.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 3.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  Vanilloids selectively sensitize thermal glutamate release from TRPV1 expressing solitary tract afferents.

Authors:  Mackenzie E Hofmann; Michael C Andresen
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 5.  TRPs in taste and chemesthesis.

Authors:  Stephen D Roper
Journal:  Handb Exp Pharmacol       Date:  2014

Review 6.  Phosphoinositide regulation of TRPV1 revisited.

Authors:  Tibor Rohacs
Journal:  Pflugers Arch       Date:  2015-03-11       Impact factor: 3.657

7.  Role for the TRPV1 channel in insulin secretion from pancreatic beta cells.

Authors:  Carlos Manlio Diaz-Garcia; Sara L Morales-Lázaro; Carmen Sánchez-Soto; Myrian Velasco; Tamara Rosenbaum; Marcia Hiriart
Journal:  J Membr Biol       Date:  2014-03-28       Impact factor: 1.843

8.  eIF2α phosphorylation controls thermal nociception.

Authors:  Arkady Khoutorsky; Robert E Sorge; Masha Prager-Khoutorsky; Sophie Anne Pawlowski; Geraldine Longo; Seyed Mehdi Jafarnejad; Soroush Tahmasebi; Loren J Martin; Mark H Pitcher; Christos G Gkogkas; Reza Sharif-Naeini; Alfredo Ribeiro-da-Silva; Charles W Bourque; Fernando Cervero; Jeffrey S Mogil; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

9.  TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain.

Authors:  Miguel Ortíz-Rentería; Rebeca Juárez-Contreras; Ricardo González-Ramírez; León D Islas; Félix Sierra-Ramírez; Itzel Llorente; Sidney A Simon; Marcia Hiriart; Tamara Rosenbaum; Sara L Morales-Lázaro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

10.  Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs.

Authors:  Sara L Morales-Lázaro; Barbara Serrano-Flores; Itzel Llorente; Enrique Hernández-García; Ricardo González-Ramírez; Souvik Banerjee; Duane Miller; Veeresh Gududuru; James Fells; Derek Norman; Gabor Tigyi; Diana Escalante-Alcalde; Tamara Rosenbaum
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.